Meg Jardine's Publications

• Trends and perspectives for improving quality of chronic kidney disease care: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

  Journal articles

  2023

  Kidney International

• Duration and effectiveness of glucose-lowering regimens in the real world management of diabetes: Data from the Australian EXTEND45 Linked Cohort Study

  Journal articles

  2023

  Endocrine and Metabolic Science

• Managing the symptom burden associated with maintenance dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

  Journal articles

  2023

  Kidney International

• Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study

  Journal articles

  2023

  European Heart Journal - Quality of Care and Clinical Outcomes

• The sodium-glucose cotransporter-2 inhibitor canagliflozin does not increase risk of non-genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double-blind trials

  Journal articles

  2023

  Diabetes, Obesity and Metabolism

• Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials

  Journal articles

  2023

  Journal of the American Heart Association

• A meta-analysis of GFR slope as a surrogate endpoint for kidney failure

  Journal articles

  2023

  Nature Medicine

• Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada

  Journal articles

  2023

  Kidney Medicine

• Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial

  Journal articles

  2023

  American Journal of Kidney Diseases

• Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering

  Journal articles

  2023

  BMJ Open Diabetes Research and Care

• The impact of dexmedetomidine on postoperative delirium: should we throw out a DECADE of research?

  Journal articles

  2023

  British Journal of Anaesthesia

• Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR: A Post Hoc Analysis of the CREDENCE Trial

  Journal articles

  2023

  Clinical journal of the American Society of Nephrology : CJASN

• Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

  Journal articles

  2023

  The Lancet

• Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: A post hoc analysis of the CREDENCE trial

  Journal articles

  2023

  Diabetes, Obesity and Metabolism

• Sex and Gender in Randomized Controlled Trials of Adults Receiving Maintenance Dialysis: A Meta-epidemiologic Study

  Journal articles

  2023

  American Journal of Kidney Diseases

• Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKD

  Journal articles

  2023

  Clinical Journal of the American Society of Nephrology

• Treatment effect of canagliflozin for patients on therapy for heart failure: Pooled analysis of the CANVAS program and CREDENCE trial

  Journal articles

  2023

  International Journal of Cardiology

• Prognostic Significance of Baseline Blood Glucose Levels and Glucose Variability in Severe Acute Kidney Injury: A Secondary Analysis from the RENAL Study

  Journal articles

  2023

  Journal of Clinical Medicine

• Comparing survival in patients with chronic kidney disease across three countries Results from the study of heart and renal protection-extended review

  Journal articles

  2023

  Nephrology

• Continued Improvement of Itch-Related Quality of Life in CKD-Associated Pruritis (CKD-aP) Patients Treated with Difelikefalin

  Journal articles

  2023

  Journal of the American Society of Nephrology

• The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset

  Journal articles

  2023

  Journal of the American Society of Nephrology

• Iron Biomarkers and Effects of Canagliflozin in Patients with Type 2 Diabetes and CKD: A Post Hoc Analysis of the CREDENCE Trial

  Journal articles

  2023

  Journal of the American Society of Nephrology

• Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients with Type 2 Diabetes and CKD: A Post Hoc Analysis of the CREDENCE Trial

  Journal articles

  2023

  Journal of the American Society of Nephrology

• The prevalence of chronic kidney disease in Australian primary care: analysis of a national general practice dataset

  Preprints

  2023

• Estimating the population-level kidney benefits of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease in Australian primary care

  Preprints

  2023

• WCN23-1085 A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ATRASENTAN IN PATIENTS WITH IGA NEPHROPATY- THE ALIGN STUDY

  Journal articles

  2023

  Kidney International Reports